A Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery (Ob-Card)

November 9, 2023 updated by: University of Leicester

An Observational Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery

This is a prospective, single-centre case control comparison of expression of target genes responsible for energy utilisation, mitochondrial function and oxidative stress and levels of histone acetylation/ DNA methylation in obese and non-obese adult cardiac surgery patients. The study aims to test several inter-related hypotheses in a consecutive sequence of patients undergoing coronary artery bypass grafting.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Leicestershire
      • Glenfield, Leicestershire, United Kingdom, LE3 9QP
        • Recruiting
        • England

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The study will be carried out at a large tertiary academic cardiac surgery unit in the UK; the University Hospitals of Leicester NHS Trust. This unit performs over 1,200 major cardiac procedures per year, of which 600 are patients undergoing coronary artery bypass grafting

Description

Inclusion Criteria:

  • Patients with pre-existing paroxysmal, persistent or chronic atrial fibrillation,

Exclusion Criteria:

  • Patients with pre-existing inflammatory state: sepsis undergoing treatment, acute kidney injury within 5 days, chronic inflammatory disease, congestive heart failure.
  • Emergency or salvage procedure.
  • Ejection fraction <30 %.
  • Patient in a critical preoperative state (Kidney Disease: Improving Global Outcomes (KDIGO) Stage 3 AKI [20] or requiring inotropes, ventilation or intra-aortic balloon pump).
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post surgery inotrope score
Time Frame: inotrope score measured up to 48 hours post-surgery
inotrope score measured up to 48 hours post-surgery
inotrope score measured up to 48 hours post-surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in expression of target genes
Time Frame: Collected at the time of surgery
from right atrial biopsies
Collected at the time of surgery
Changes in epigenetic regulation of target genes from left atrial biopsies.
Time Frame: Collected at the time of surgery
histone acetylation, DNA methylation
Collected at the time of surgery
Changes in mitochondrial function
Time Frame: before and after sugery (up to 12 hours post surgery)
in atrial biopsies and buffy coats of blood samples collected before and after surgery
before and after sugery (up to 12 hours post surgery)
Myocardial Injury
Time Frame: baseline and 24 hours
defined by post cardiac surgery serum Troponin levels
baseline and 24 hours
Acute kidney injury
Time Frame: baseline, and up to 15 days post surgery (discharge)
defined by serum creatinine level postoperatively, as per the KDIGO criteria
baseline, and up to 15 days post surgery (discharge)
Perioperative clinical characteristics
Time Frame: Collected pre op
Perioperative clinical characteristics
Collected pre op
Perioperative medications.
Time Frame: Collected pre op
Perioperative medications.
Collected pre op
Data to calculate Multiple Organ Dysfunction (MOD) score.
Time Frame: baseline, and up to 96 hours post surgery
To calculate the MOD score, the Respiratory Function (calculated as partial pressure of oxygen (PaO2) divided by fraction of inspired oxygen (FiO2)), Cardiovascular (Pressure adjusted heart rate (PAR) ), Renal (Serum Creatinine), Hepatic (serum bilirubi
baseline, and up to 96 hours post surgery
Data to capture Acute Respiratory Distress Syndrome (Berlin criteria ARDS).
Time Frame: baseline, and up to 96 hours post surgery
Acute Lung Injury (ALI) non-ARDS, ARDS. To define these different categories of acute lung injury, the Positive end-expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) will be recorded in the CRF at time points: Pre-OP, ICU, 12 hrs post-op,24hrs post-op,48hrs post-op,72hrs post-op and 96hrs post-op. Along with the PaO2/FiO2 ratio, it will then be possible to categorise patients into the above definitions of acute lung injury as follows: ALI non-ARDS (200 mmHg <PaO2/FiO2<300 mmHg, regardless of PEEP),ARDS (PaO2/FiO2<200 mmHg, regardless of PEEP), mild Berlin Definition(200mmHg <PaO2/FiO2<300mmHg with PEEP > 5cm H2O),moderate Berlin Definition(100mmHg <calculated as partial pressure of oxygen divided by fraction of inspired oxygen PaO2/FiO2 < 200mmHg with PEEP > 5cm H2O) and Severe Berlin Definition (PaO2/FiO2 < 100mmHg with PEEP > 5cm H2O)
baseline, and up to 96 hours post surgery
Data on demographics
Time Frame: Pre Op
Height in cms
Pre Op
Data on demographics
Time Frame: Pre Op
Weight in kgs
Pre Op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gavin Murphy, University of Leicester
  • Principal Investigator: Filiberto Serraino, University of Leicester

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 9, 2016

Primary Completion (Estimated)

October 7, 2024

Study Completion (Estimated)

October 7, 2024

Study Registration Dates

First Submitted

July 19, 2016

First Submitted That Met QC Criteria

September 15, 2016

First Posted (Estimated)

September 20, 2016

Study Record Updates

Last Update Posted (Estimated)

November 14, 2023

Last Update Submitted That Met QC Criteria

November 9, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 0574

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on C.Surgical Procedure; Cardiac

Subscribe